Showing results (91-100 of 108) with videos related to
Sort By:
Pageof 11
Oncotarget|November 9, 2018
The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancerEl-Habib Dakir, Adam Pickard, Kirtiman Srivastava, et al.Australian and New Zealand Journal of Public Health|June 4, 2014
Characteristics of health impact assessments reported in Australia and New Zealand 2005-2009Fiona Haigh, Elizabeth Harris, Harrison N G Chok, et al.International Journal of Cancer|February 13, 2013
The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathwayM Cristina Errico, Federica Felicetti, Lisabianca Bottero, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2012
CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosisTao Fu, Emmanouil P Pappou, Angela A Guzzetta, et al.Frontiers in Immunology|April 27, 2018
<i>In Silico</i> and Structural Analyses Demonstrate That Intrinsic Protein Motions Guide T Cell Receptor Complementarity Determining Region Loop FlexibilityChristopher J Holland, Bruce J MacLachlan, Valentina Bianchi, et al.European Journal of Cancer (Oxford, England : 1990)|February 26, 2013
Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarkerRichard Morgan, Richard T Bryan, Saqib Javed, et al.Oncotarget|October 8, 2016
Ran GTPase promotes cancer progression via Met recepto-rmediated downstream signalingHiu-Fung Yuen, Ka-Kui Chan, Angela Platt-Higgins, et al.Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Omics Integration Uncovers Mechanisms Associated with HIV Viral Load and Potential Therapeutic InsightsKyle A Sullivan, Melyssa S Minto, Xinyu Zhang, et al.BMC Cancer|April 14, 2022
HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiformeEinthavy Arunachalam, William Rogers, Guy R Simpson, et al.BMC Cancer|August 28, 2012
Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathwayKatie Twigger, Victoria Roulstone, Joan Kyula, et al.Pageof 11